{"slug":"ss-31-insomnia","title":"SS-31 (Elamipretide) for Insomnia: Evidence Review","body":"## What's breaking down\n\nInsomnia often links to cycles where poor sleep increases oxidative stress and inflammation in brain cells. Mitochondria in neurons produce less efficient energy. This can worsen cognitive fog and make sustained sleep harder. Degeneration outpaces repair when mitochondrial cardiolipin gets damaged, leading to more reactive oxygen species and weaker synaptic function. SS-31 targets that mitochondrial layer for potential repair rather than symptom suppression.\n\n## Why SS-31 (Elamipretide) might help you\n\nIf mitochondrial dysfunction in brain cells contributes to your insomnia pattern, SS-31 is discussed because it binds cardiolipin in the inner mitochondrial membrane. Step 1: It stabilizes electron transport chain efficiency. Step 2: This reduces excess ROS production during sleep-deprived states. Step 3: Lower ROS and inflammation may support better synaptic plasticity and energy availability overnight. Therefore for you: If that layer is part of your problem, SS-31 (Elamipretide) is discussed because it targets repair (tissue) — not because it masks pain or forces drowsiness.\n\n## How these fit together\n\nSingle-compound focus. SS-31 (Elamipretide) maps to the mitochondrial degeneration layer. No siblings in scope.\n\n## What the evidence actually shows\n\nTwo mouse studies address sleep deprivation models directly. Zhang 2024 gave chronic sleep deprivation to mice then treated with elamipretide; it restored SIRT1 and PGC-1α levels, lowered inflammatory cytokines (IL-1β, IL-6, TNF-α), and improved learning/memory performance (preclinical). Wu 2020 used short-term sleep deprivation in aging mice; SS-31 prevented learning deficits, restored hippocampal mitochondrial ATP, and lowered ROS plus cytokines (preclinical). No human trials test SS-31 for insomnia or primary sleep outcomes. Human data come from mitochondrial myopathy and heart failure trials showing mixed fatigue or exercise results (human).\n\n## What scientists say\n\nThe 2024 mouse paper concludes SS-31 “could be a novel agent for patients with chronic insomnia-associated cognitive impairment” but calls for future studies (preclinical). The 2020 paper notes possible therapeutic benefits for acute sleep loss effects in aging models (preclinical). Broader reviews on elamipretide focus on mitochondrial diseases without insomnia-specific claims (mechanistic).\n\n## What people say on Reddit\n\nAnecdotes in r/cfs and r/Peptides vary. Some users report improved daytime energy without sleep interference or even better total sleep time per trackers, though deep/REM sometimes dropped (anecdotal). Others note insomnia flares, heart rate increases, or no sleep change; a few describe initial energy that later plateaus (anecdotal). No consistent pattern of direct insomnia relief emerges.\n\n## What people say on X\n\nLimited public discussion tied to insomnia; mentions focus on general energy or fatigue in mitochondrial contexts with no verified sleep-specific reports surfacing in searches (anecdotal).\n\n## What we do not know\n\nNo human randomized trials exist for SS-31 in insomnia. Long-term effects on sleep architecture remain unstudied. Optimal dosing or duration for any sleep-related layer is unknown. Translation from mouse sleep-deprivation models to human chronic insomnia is unproven.\n\n## Safety and limits\n\nHuman trials report generally good short-term tolerability with mild side effects like headache or fatigue in some (human). Individual Reddit reports include autonomic flares or injection-site issues (anecdotal). SS-31 remains investigational outside specific mitochondrial indications; evidence grade for insomnia stays preclinical or anecdotal.","register":"source_ledger","tags":["peptide","matrix"],"category":null,"style":{},"claims":[{"id":"c1","text":"Zhang 2024 mouse study: elamipretide restored mitochondrial biogenesis markers and reduced inflammation after chronic sleep deprivation, improving cognition.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s1"],"source_status":"sourced","why_material":"Direct preclinical link to sleep deprivation model and cognitive repair."},{"id":"c2","text":"Wu 2020 mouse study: SS-31 prevented learning impairment and restored mitochondrial ATP while lowering ROS after short-term sleep deprivation in aged mice.","section":"What the evidence actually shows","tier":"preclinical","source_ids":["s2"],"source_status":"sourced","why_material":"Shows mitochondrial protection mechanism relevant to sleep loss effects."},{"id":"c3","text":"No human trials test SS-31 specifically for insomnia or sleep quality endpoints.","section":"What we do not know","tier":"human","source_ids":["s3"],"source_status":"sourced","why_material":"Clarifies evidence gap for the target condition."},{"id":"c4","text":"Reddit users report mixed effects on energy and sleep with SS-31, including occasional insomnia flares or improved total sleep time.","section":"What people say on Reddit","tier":"anecdotal","source_ids":["s4"],"source_status":"sourced","why_material":"Captures real-world user observations separate from trials."}],"sources":[{"id":"s1","type":"pubmed","url":"https://onlinelibrary.wiley.com/doi/full/10.1002/brb3.3508","title":"Mitochondrial antioxidant elamipretide improves learning and memory impairment induced by chronic sleep deprivation in mice","quote":"This work suggests that SS-31 could be a novel agent for patients with chronic insomnia-associated cognitive impairment.","summary":"2024 mouse study on chronic sleep deprivation and elamipretide effects on cognition and mitochondria.","claim_ids":["c1"]},{"id":"s2","type":"pubmed","url":"https://pmc.ncbi.nlm.nih.gov/articles/PMC7573804/","title":"Adverse Neurological Effects of Short-Term Sleep Deprivation in Aging Mice Are Prevented by SS31 Peptide","quote":"The observations suggest possible therapeutic benefits of SS31 for alleviating adverse neurological effects of acute sleep loss.","summary":"2020 study showing SS-31 protection against sleep deprivation neurological effects in mice.","claim_ids":["c2"]},{"id":"s3","type":"review","url":"https://www.alzdiscovery.org/uploads/cognitive_vitality_media/SS-31-Cognitive-Vitality-For-Researchers.pdf","title":"SS-31 (also known as Elamipretide®, Bendavia®, and MTP-131)","quote":"Preclinical studies showed benefit in cognitive impairment... Clinical trials in heart failure and primary mitochondrial myopathy have failed.","summary":"Overview noting lack of insomnia-specific human data and mixed trial outcomes.","claim_ids":["c3"]},{"id":"s4","type":"reddit","url":"https://www.reddit.com/r/cfs/comments/1j2upcm/my_experience_treating_my_mecfs_with/","title":"My Experience Treating my ME/CFS with mitochondrial peptides (SS-31)","quote":"SS-31 has been the single most effective treatment I have tried for improving energy. It has improved my cognitive function by 50%.","summary":"User reports on SS-31 effects including energy and occasional sleep notes from multiple threads.","claim_ids":["c4"]}],"prov":{"model":"grok/grok-4.3","action":"write"}}